Maren F. Hansen

Maren F. Hansen

Auto-generated profile, based on publicly available information

Maren F. Hansen

Department of Laboratory Medicine, Children's and Women's Health, Norwegian University of Science and Technology (NTNU), Trondheim, Norway

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 February 2017 in Clinical Genetics
Verified
Journal Article
Open access
PDF file
MHMaren F. Hansen
Maren F. Hansen
JJJostein Johansen
Jostein Johansen
ASAnna E. Sylvander
Anna E. Sylvander
IBInga Bjørnevoll
Inga Bjørnevoll
BTBente A. Talseth‐Palmer
Bente A. Talseth‐Palmer
WSWenche Sjursen
Wenche Sjursen
Background: Many families with a high burden of colorectal cancer fulfil the clinical criteria for Lynch Syndrome. However, in about half of these families, no germline mutation in the mismatch repair genes known to be associated with this disease can be identified. The aim of this study was to find the genetic cause for the increased colorectal cancer risk in these unsolved cases.Materials and methods: To reach the aim, we designed a gene panel targeting 112 previously known or candidate colorectal cancer susceptibility genes to screen 274 patient samples for mutations. Mutations were validated by Sanger sequencing and, where possible, segregation analysis was performed.Results: We identified 73 interesting variants, of whom 17 were pathogenic and 19 were variants of unknown clinical significance in well‐established cancer susceptibility genes. In addition, 37 potentially pathogenic variants in candidate colorectal cancer susceptibility genes were detected.Conclusion: In conclusion, we found a promising DNA variant in more than 25 % of the patients, which shows that gene panel testing is a more effective method to identify germline variants in CRC patients compared to a single gene approach.